BELFAST centenarians: A case of optimal cardiovascular risk?

E. Bennati, A. Murphy, F. Cambien, A.S. Whitehead, G.P.R. Archbold, I.S. Young, I.M. Rea

    Research output: Contribution to journal › Article

    16 Citations (Scopus)
    LanguageEnglish
    Pages789-795
    JournalCurrent Pharmaceutical Design
    Volume16
    Issue number7
    DOIs
    Publication statusPublished - 2010

    Keywords

    • ACE
    • Anti-oxidants
    • Apoe
    • BELFAST
    • Centenarians
    • Cholesterol
    • Malondiadehyde
    • Mortality

    Cite this

    Bennati, E., Murphy, A., Cambien, F., Whitehead, A. S., Archbold, G. P. R., Young, I. S., & Rea, I. M. (2010). BELFAST centenarians: A case of optimal cardiovascular risk? Current Pharmaceutical Design, 16(7), 789-795. https://doi.org/10.2174/138161210790883697
    Bennati, E. ; Murphy, A. ; Cambien, F. ; Whitehead, A.S. ; Archbold, G.P.R. ; Young, I.S. ; Rea, I.M. / BELFAST centenarians: A case of optimal cardiovascular risk?. In: Current Pharmaceutical Design. 2010 ; Vol. 16, No. 7. pp. 789-795.
    @article{34a8d66e2dda4568a910d44f98d456d4,
    title = "BELFAST centenarians: A case of optimal cardiovascular risk?",
    keywords = "ACE, Anti-oxidants, Apoe, BELFAST, Centenarians, Cholesterol, Malondiadehyde, Mortality",
    author = "E. Bennati and A. Murphy and F. Cambien and A.S. Whitehead and G.P.R. Archbold and I.S. Young and I.M. Rea",
    note = "cited By 13",
    year = "2010",
    doi = "10.2174/138161210790883697",
    language = "English",
    volume = "16",
    pages = "789--795",
    journal = "Current Pharmaceutical Design",
    issn = "1381-6128",
    number = "7",

    }

    Bennati, E, Murphy, A, Cambien, F, Whitehead, AS, Archbold, GPR, Young, IS & Rea, IM 2010, 'BELFAST centenarians: A case of optimal cardiovascular risk?', Current Pharmaceutical Design, vol. 16, no. 7, pp. 789-795. https://doi.org/10.2174/138161210790883697

    BELFAST centenarians: A case of optimal cardiovascular risk? / Bennati, E.; Murphy, A.; Cambien, F.; Whitehead, A.S.; Archbold, G.P.R.; Young, I.S.; Rea, I.M.

    In: Current Pharmaceutical Design, Vol. 16, No. 7, 2010, p. 789-795.

    Research output: Contribution to journal › Article

    TY - JOUR

    T1 - BELFAST centenarians: A case of optimal cardiovascular risk?

    AU - Bennati, E.

    AU - Murphy, A.

    AU - Cambien, F.

    AU - Whitehead, A.S.

    AU - Archbold, G.P.R.

    AU - Young, I.S.

    AU - Rea, I.M.

    N1 - cited By 13

    PY - 2010

    Y1 - 2010

    KW - ACE

    KW - Anti-oxidants

    KW - Apoe

    KW - BELFAST

    KW - Centenarians

    KW - Cholesterol

    KW - Malondiadehyde

    KW - Mortality

    U2 - 10.2174/138161210790883697

    DO - 10.2174/138161210790883697

    M3 - Article

    VL - 16

    SP - 789

    EP - 795

    JO - Current Pharmaceutical Design

    T2 - Current Pharmaceutical Design

    JF - Current Pharmaceutical Design

    SN - 1381-6128

    IS - 7

    ER -

    Bennati E, Murphy A, Cambien F, Whitehead AS, Archbold GPR, Young IS et al. BELFAST centenarians: A case of optimal cardiovascular risk? Current Pharmaceutical Design. 2010;16(7):789-795. https://doi.org/10.2174/138161210790883697

    Access to Document